Search anything
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
KEC International’s Q4 FY26 profit and revenue miss pushed the stock near its 52-week low, prompting Axis Direct, PL Capital and HDFC Securities to cut targets while retaining ratings.
Whirlpool of India reported higher Q4 FY25 profit helped by improved margins and an insurance gain, and recommended a ₹5 final dividend for FY25 amid mixed share reaction.
UN and multiple agencies trimmed India’s FY27 growth projections as the West Asia conflict lifts crude prices, tightens financial conditions, and raises inflation and subsidy pressures.
JSW Dulux reported FY26 PAT of ₹1,973.8 crore driven by ₹1,845.9 crore exceptional gains from divestments, even as revenue from operations fell 12% and Q4 volumes rose 23%.
Motilal Oswal reiterated Buy on Varun Beverages, lifting its target to Rs 600 as earnings strengthened, margins improved and summer demand could rise amid heatwave forecasts.
The RBI will run a $5 billion USD/INR buy-sell swap auction for a three-year tenor, with $10 million minimum bids, to inject long-term rupee liquidity.
Dr Reddy’s secured CDSCO approval for generic oral semaglutide tablets and launched DCGI-approved Obeda injections at ₹4,200 per month, as patent and pricing battles intensify in India.
Sammaan Capital (formerly Indiabulls Housing Finance) reported a sharp Q4 FY26 loss after exceptional charges, impairment and higher Ind AS 109 provisions, alongside a year-on-year income decline.
Apollo Hospitals reported strong Q4 FY25 earnings, declared a Rs 10 final dividend with an August 19, 2025 record date, and later announced an interim dividend for FY26.
Apollo Hospitals’ Q4 FY25 profit rose 53.5% year-on-year to ₹390 crore on 13% revenue growth, while the board recommended a final dividend of ₹10 per share.
Social media debate is sharpening around record USD-INR levels, crude above $100, and foreign outflows, raising questions on inflation, the current account deficit, and RBI intervention.
Capital Infra Trust reported FY26 results with AUM up 42% YoY to ₹66,114 Mn, NAV at ₹74.72, FY26 distribution of ₹11.60 per unit, and a 7.3% effective interest rate.
Lactose (India) reported standalone Q2 Sep 2025 net sales of ₹41.18 crore, raised lactose capacity to 15,000 MT a year, and its stock gained 5.8%.
RVNL rose over 6% after becoming L1 for an East Coast Railway EPC job near Rs 968 crore, adding to recent LoAs totaling over Rs 2,500 crore.
The rupee’s slide to near Rs 96 per dollar reflects the U.S.-Iran war’s oil shock, foreign outflows, wider deficits, and RBI moves to curb volatility.
Colliers India estimates solar and wind buildouts could require about 7 lakh acres and unlock USD 10-15 billion in land deals, while driving warehousing demand by 2030.
